O Brien Greene & Co. Inc Sells 8,419 Shares of Nutrien Ltd. (NYSE:NTR)

O Brien Greene & Co. Inc reduced its holdings in shares of Nutrien Ltd. (NYSE:NTR) by 6.0% in the third quarter, HoldingsChannel reports. The fund owned 132,542 shares of the company’s stock after selling 8,419 shares during the period. Nutrien accounts for 2.0% of O Brien Greene & Co. Inc’s portfolio, making the stock its 24th biggest holding. O Brien Greene & Co. Inc’s holdings in Nutrien were worth $6,370,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Bank of Montreal Can raised its position in shares of Nutrien by 15.5% in the 2nd quarter. Bank of Montreal Can now owns 13,354,385 shares of the company’s stock worth $719,668,000 after purchasing an additional 1,794,333 shares during the last quarter. Silchester International Investors LLP raised its holdings in Nutrien by 164.4% in the third quarter. Silchester International Investors LLP now owns 10,683,242 shares of the company’s stock worth $513,437,000 after buying an additional 6,642,075 shares during the last quarter. 1832 Asset Management L.P. lifted its stake in shares of Nutrien by 1.9% in the second quarter. 1832 Asset Management L.P. now owns 9,006,528 shares of the company’s stock worth $458,522,000 after buying an additional 167,312 shares in the last quarter. Altshuler Shaham Ltd grew its holdings in shares of Nutrien by 8.1% during the second quarter. Altshuler Shaham Ltd now owns 5,990,374 shares of the company’s stock valued at $304,970,000 after buying an additional 446,340 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its position in shares of Nutrien by 8.4% during the second quarter. Dimensional Fund Advisors LP now owns 5,145,375 shares of the company’s stock valued at $261,985,000 after acquiring an additional 399,348 shares in the last quarter. Institutional investors own 63.10% of the company’s stock.

Nutrien Price Performance

Shares of Nutrien stock opened at $47.93 on Monday. The stock’s fifty day moving average is $47.96 and its 200 day moving average is $49.33. Nutrien Ltd. has a one year low of $44.65 and a one year high of $60.87. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.82 and a current ratio of 1.27. The stock has a market cap of $23.67 billion, a P/E ratio of 32.17, a P/E/G ratio of 1.69 and a beta of 0.80.

Nutrien (NYSE:NTR) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $0.39 earnings per share for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.04). The company had revenue of $5.35 billion for the quarter, compared to analysts’ expectations of $5.26 billion. Nutrien had a net margin of 2.79% and a return on equity of 6.99%. The firm’s quarterly revenue was down 5.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.35 earnings per share. Sell-side analysts anticipate that Nutrien Ltd. will post 3.54 earnings per share for the current year.

Nutrien Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 17th. Stockholders of record on Tuesday, December 31st will be paid a $0.939 dividend. The ex-dividend date is Tuesday, December 31st. This is a boost from Nutrien’s previous quarterly dividend of $0.54. This represents a $3.76 dividend on an annualized basis and a dividend yield of 7.84%. Nutrien’s dividend payout ratio is 144.97%.

Analyst Ratings Changes

Several research firms recently issued reports on NTR. Barclays lowered their price objective on Nutrien from $68.00 to $55.00 and set an “overweight” rating on the stock in a research report on Friday, August 16th. UBS Group downgraded Nutrien from a “buy” rating to a “neutral” rating and lowered their price target for the company from $66.00 to $51.00 in a report on Thursday, October 10th. Wells Fargo & Company downgraded Nutrien from an “overweight” rating to an “equal weight” rating and reduced their price objective for the stock from $62.00 to $50.00 in a report on Tuesday, September 24th. The Goldman Sachs Group cut shares of Nutrien from a “buy” rating to a “neutral” rating and lowered their target price for the company from $69.00 to $53.00 in a research note on Tuesday, September 10th. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $60.00 price target on shares of Nutrien in a research note on Friday, September 20th. Three equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $60.06.

Nutrien Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.